Home > Financial Ratios > AARTI PHARMALABS

AARTI PHARMALABS
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for AARTI PHARMALABS
Please provide your vote to see the results

AARTI PHARMALABS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 15.1210.707.811.22-3.76

What is the latest EV/Core EBITDA ratio of AARTI PHARMALABS ?

The latest EV/Core EBITDA ratio of AARTI PHARMALABS is 15.12 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202515.12
Mar202410.70
Mar20237.81
Mar20221.22
Mar2021-3.76

How is EV/Core EBITDA of AARTI PHARMALABS Trending?

Years EV/Core EBITDA % Change
Mar2025 15.12
41.31
Mar2024 10.7
37.00
Mar2023 7.81
540.16
Mar2022 1.22
Positive
Mar2021 -3.76 -

Other Financial Ratios of AARTI PHARMALABS


Compare EV/Core EBITDA ratio of peers of AARTI PHARMALABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI PHARMALABS ₹6,906.9 Cr -11.1% -9.1% 33% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,287.0 Cr -0.6% 4% -6.4% Stock Analytics
DIVIS LABORATORIES ₹177,657.0 Cr -1.7% 9.3% 12.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹129,202.0 Cr 5.2% 7% 11.9% Stock Analytics
CIPLA ₹122,276.0 Cr 0.1% 1.3% -5.1% Stock Analytics
DR REDDYS LABORATORIES ₹100,024.0 Cr 0.2% -2.9% -4.9% Stock Analytics


AARTI PHARMALABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI PHARMALABS

-11.1%

-9.1%

33%

SENSEX

-0.5%

2%

4.8%


You may also like the below Video Courses